openPR Logo
Press release

PreDiabetes Pipeline 2024: Key Developments, Emerging Therapies, and Clinical Trials Detailed Analysis by DelveInsight | NanoPrecision Medical, Caelus Health, Inversago Pharma Inc., Haisco Pharma

01-21-2025 02:54 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

PreDiabetes Pipeline 2024: Key Developments, Emerging

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, PreDiabetes pipeline constitutes 15+ key companies continuously working towards developing 15+ PreDiabetes treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"PreDiabetes Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the PreDiabetes Market.

The PreDiabetes Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the PreDiabetes Pipeline Report:

*
Companies across the globe are diligently working toward developing novel PreDiabetes treatment therapies with a considerable amount of success over the years.

*
PreDiabetes companies working in the treatment market are NanoPrecision Medical, Caelus Health, Inversago Pharma Inc., Haisco Pharmaceutical Group Co., Ltd., Valbiotis, Resverlogix, Boston Therapeutics, and others, are developing therapies for the PreDiabetes treatment

*
Emerging PreDiabetes therapies in the different phases of clinical trials are- OKV-119, Anaerostipes rhamnosivorans, Intestinimonas, INV-202, HSK7653, Eubacterium Hallii, Totum-63, Apabetalone, BTI-320, and others are expected to have a significant impact on the PreDiabetes market in the coming years.

*
In November 2024, Eli Lilly and Company (NYSE: LLY) released detailed results from the Phase 3 SURMOUNT-1 three-year study (176-week treatment period), which is the longest completed study of tirzepatide to date. Weekly injections of tirzepatide (Zepbound Registered and Mounjaro Registered ) at combined doses of 5 mg, 10 mg, and 15 mg significantly reduced the risk of progression to type 2 diabetes in adults with pre-diabetes and obesity or overweight, compared to a placebo, over the 176-week period. Tirzepatide also showed sustained average weight loss of 22.9% (with the 15 mg dose) throughout the three-year treatment period for the efficacy group.

PreDiabetes Overview

Pre-diabetes is a condition characterized by blood glucose levels that are higher than normal but not yet high enough to be diagnosed as type 2 diabetes. It's considered an intermediate stage between normal glucose levels and diabetes. Individuals with pre-diabetes are at increased risk of developing type 2 diabetes, heart disease, and stroke. However, pre-diabetes can often be reversed through lifestyle changes such as weight loss, healthy eating, and increased physical activity. Regular monitoring and early intervention can help prevent or delay the onset of type 2 diabetes in individuals with pre-diabetes.

Get a Free Sample PDF Report to know more about PreDiabetes Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/prediabetes-pipeline-insight [https://www.delveinsight.com/report-store/prediabetes-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Emerging PreDiabetes Drugs Under Different Phases of Clinical Development Include:

*
OKV-119: NanoPrecision Medical

*
Anaerostipes rhamnosivorans: Caelus Health

*
Intestinimonas: Caelus Health

*
INV-202: Inversago Pharma Inc.

*
HSK7653: Haisco Pharmaceutical Group Co., Ltd.

*
Eubacterium Hallii: Caelus Health

*
Totum-63: Valbiotis

PreDiabetes Route of Administration

PreDiabetes pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as

*
Oral

*
Intravenous

*
Subcutaneous

PreDiabetes Molecule Type

PreDiabetes Products have been categorized under various Molecule types, such as

*
Small molecule

*
Cell Therapy

*
Peptides

*
Polymer

*
Small molecule

*
Gene therapy

PreDiabetes Pipeline Therapeutics Assessment

*
PreDiabetes Assessment by Product Type

*
PreDiabetes By Stage and Product Type

*
PreDiabetes Assessment by Route of Administration

*
PreDiabetes By Stage and Route of Administration

*
PreDiabetes Assessment by Molecule Type

*
PreDiabetes by Stage and Molecule Type

DelveInsight's PreDiabetes Report covers around 15+ products under different phases of clinical development like

*
Late-stage products (Phase III)

*
Mid-stage products (Phase II)

*
Early-stage product (Phase I)

*
Pre-clinical and Discovery stage candidates

*
Discontinued & Inactive candidates

*
Route of Administration

Further PreDiabetes product details are provided in the report. Download the PreDiabetes pipeline report to learn more about the emerging PreDiabetes therapies [https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Some of the key companies in the PreDiabetes Therapeutics Market include:

Key companies developing therapies for PreDiabetes are - Resverlogix Corporation, Boston Therapeutics, vTv Therapeutics, Valbiotis, BioTeSys, SynDevRx, Caelus Health, NanoPrecision Medical, and others.

PreDiabetes Pipeline Analysis:

The PreDiabetes pipeline report provides insights into

*
The report provides detailed insights about companies that are developing therapies for the treatment of PreDiabetes with aggregate therapies developed by each company for the same.

*
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for PreDiabetes Treatment.

*
PreDiabetes key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

*
PreDiabetes Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the PreDiabetes market.

The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about PreDiabetes drugs and therapies [https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

PreDiabetes Pipeline Market Drivers

*
Increase in prevalence of prediabetes, increase in Diagnosis and Growing investments in research and development are some of the important factors that are fueling the PreDiabetes Market.

PreDiabetes Pipeline Market Barriers

*
However, side effects associated with Drugs, lack of Awareness among Patients and other factors are creating obstacles in the PreDiabetes Market growth.

Scope of PreDiabetes Pipeline Drug Insight

*
Coverage: Global

*
Key PreDiabetes Companies: NanoPrecision Medical, Caelus Health, Inversago Pharma Inc., Haisco Pharmaceutical Group Co., Ltd., Valbiotis, Resverlogix, Boston Therapeutics, and others

*
Key PreDiabetes Therapies: OKV-119, Anaerostipes rhamnosivorans, Intestinimonas, INV-202, HSK7653, Eubacterium Hallii, Totum-63, Apabetalone, BTI-320, and others

*
PreDiabetes Therapeutic Assessment: PreDiabetes current marketed and PreDiabetes emerging therapies

*
PreDiabetes Market Dynamics: PreDiabetes market drivers and PreDiabetes market barriers

Request for Sample PDF Report for PreDiabetes Pipeline Assessment and clinical trials [https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1. PreDiabetes Report Introduction

2. PreDiabetes Executive Summary

3. PreDiabetes Overview

4. PreDiabetes- Analytical Perspective In-depth Commercial Assessment

5. PreDiabetes Pipeline Therapeutics

6. PreDiabetes Late Stage Products (Phase II/III)

7. PreDiabetes Mid Stage Products (Phase II)

8. PreDiabetes Early Stage Products (Phase I)

9. PreDiabetes Preclinical Stage Products

10. PreDiabetes Therapeutics Assessment

11. PreDiabetes Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. PreDiabetes Key Companies

14. PreDiabetes Key Products

15. PreDiabetes Unmet Needs

16 . PreDiabetes Market Drivers and Barriers

17. PreDiabetes Future Perspectives and Conclusion

18. PreDiabetes Analyst Views

19. Appendix

20. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=prediabetes-pipeline-2024-key-developments-emerging-therapies-and-clinical-trials-detailed-analysis-by-delveinsight-nanoprecision-medical-caelus-health-inversago-pharma-inc-haisco-pharma]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PreDiabetes Pipeline 2024: Key Developments, Emerging Therapies, and Clinical Trials Detailed Analysis by DelveInsight | NanoPrecision Medical, Caelus Health, Inversago Pharma Inc., Haisco Pharma here

News-ID: 3825641 • Views:

More Releases from ABNewswire

Chronic Inflammatory Demyelinating Polyneuropathy Market Expected to rise, 2034 | ICSL Behring, Grifols, Kedrion Biopharma, Nihon Pharmaceutical, LFB, Teijin Pharma, OctaPharma, Shire, Takeda, UCB Bio
Chronic Inflammatory Demyelinating Polyneuropathy Market Expected to rise, 2034 …
The Chronic Inflammatory Demyelinating Polyneuropathy market growth is driven by factors like increase in the prevalence of Chronic Inflammatory Demyelinating Polyneuropathy, investments in research and development, entry of emerging therapies during the study period 2020-2034. The Chronic Inflammatory Demyelinating Polyneuropathy market report [https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] also offers comprehensive insights into the Chronic Inflammatory Demyelinating Polyneuropathy market size, share, Chronic Inflammatory Demyelinating Polyneuropathy epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key
Bipolar Depression Market Expected to rise, 2034 | Allergan (AbbVie)/Gedeon Richter, Sunovion Pharmaceuticals (Sumitomo Dainippon Pharma), Intra-Cellular Therapies, NeuroRx, Sunovion (Sumitomo Dainipp
Bipolar Depression Market Expected to rise, 2034 | Allergan (AbbVie)/Gedeon Rich …
The Bipolar Depression market growth is driven by factors like increase in the prevalence of Bipolar Depression, investments in research and development, entry of emerging therapies during the study period 2020-2034. The Bipolar Depression market report [https://www.delveinsight.com/report-store/bipolar-disorder-manic-depression-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] also offers comprehensive insights into the Bipolar Depression market size, share, Bipolar Depression epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and
Plumbers Lisburn Launches New Website to Connect Consumers with Reliable Plumbers in Lisburn
Plumbers Lisburn Launches New Website to Connect Consumers with Reliable Plumber …
Lisburn, UK - Feb 13, 2025 - Plumbers Lisburn is proud to announce the official launch of its brand-new website, https://plumberslisburn.co.uk/. This innovative platform is designed to connect homeowners and businesses in central Lisburn with qualified plumbers, heating engineers, and gas safe registered engineers, ensuring fast, reliable, and professional plumbing services when they are needed most. Plumbers Lisburn [https://plumberslisburn.co.uk/] provides an all-in-one solution for anyone looking for expert help with boiler
Total Restoration: Leading the Way in Commercial Water Damage Restoration in Melbourne
Total Restoration: Leading the Way in Commercial Water Damage Restoration in Mel …
Water damage can strike at any time, often leaving businesses in Melbourne scrambling to recover. Whether it's a burst pipe, flooding, or a leaky roof, the aftermath of water damage can be devastating for commercial properties. This is where Total Restoration, a trusted water damage restoration company, steps in. Specializing in commercial water damage restoration, they provide swift, efficient, and reliable services to help businesses get back on their feet.

All 5 Releases


More Releases for PreDiabetes

Growth in Blood Glucose Monitoring Market to Get Driven by Increasing Prevalence …
The global blood glucose monitoring market is expected to register a considerable CAGR as blood glucose monitoring devices enable effective monitoring of diabetes. The above information was shared by Fortune Business Insights in a report, titled "Blood Glucose Monitoring Market Size, Share and Global Trend by Product (Self-Blood Glucose Monitoring, Continuous Blood Glucose Monitoring), By Distribution Channel (Hospital & clinics pharmacies, Retail pharmacies, Online pharmacies, Others), and Geography Forecast till
Hemoglobin A1c testing devices market is estimated to account for US$ 4,129.4 Mn …
Hemoglobin A1c test is a common blood test performed for diagnosis and monitoring of type 1 and type 2 diabetes. A1c test results reflect the average blood sugar levels of an individual for the past two to three months. Hemoglobin (Hb) is a protein that links with sugars such as glucose found inside red blood cells. High amount of glucose linked (glycated) with hemoglobin molecules increases the risk of diabetes.
Glycated Albumin Assay Market Analysis 2020 | Top Players Asahi Kasei Corporatio …
The global glycated albumin assay market, by Product Type (Human Glycated Albumin Assay and Animal Glycated Albumin Assay), by Application (Diagnostics (Prediabetes, Type 1 Diabetes, and Type 2 Diabetes) and Research), by End User (Hospital, Diagnostic Centers, Research Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was estimated to be at US$ 428.1 million in 2019, and is expected to
Glycated Albumin Market - Size, Share, Trends, and Forecast
Global Glycated Albumin Market, by Product Type (Human Glycated Albumin and Animal Glycated Albumin), by Application (Diagnosis (Prediabetes, Type 1 Diabetes, and Type 2 Diabetes)) and Research), by End User (Hospitals/Clinics, Diagnostic Centers, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ XX Mn in 2017 and is projected to exhibit a CAGR of XX% over the
Digital Therapeutics Market worth 457.9 Million USD by 2021
The report "Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021. Browse 148 market data Tables and 36 Figures
Scientific Animations partners with NutritionFacts.org to spread awareness about …
Scientific Animations, a U.S. based medical animations company headquartered in California, has recently joined forces with Nutritionfacts.org to spread awareness on “insulin resistance”. The companies came together to develop a fascinating 3D medical animation video depicting the cause of prediabetes and type 2 diabetes. The video shows how fat buildup in muscle cells act as a blocking mechanism that reduce insulin sensitivity. People with insulin resistance have cells that cannot use